Cost-effectiveness of targeted screening for hepatitis C in The Netherlands
- 16 February 2011
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 140 (1) , 58-69
Abstract
SUMMARY On account of the serious complications of hepatitis C virus (HCV) infection and the improved treatment possibilities, the need to improve HCV awareness and case-finding is increasingly recognized. To optimize a future national campaign with this objective, three pilot campaigns were executed in three regions in The Netherlands. One campaign was aimed at the general population, a second (similar) campaign was extended with a support programme for primary care and a third campaign was specifically aimed at hard-drug users. Data from the pilot campaigns were used to build a mathematical model to estimate the incremental cost-effectiveness ratio of the different campaigns. The campaign aimed at the general public without support for primary care did not improve case-finding and was therefore not cost-effective. The similar campaign accompanied by additional support for primary care and the campaign aimed at hard-drug users emerged as cost-effective interventions for identification of HCV carriers.Keywords
This publication has 19 references indexed in Scilit:
- Screening and Early Treatment of Migrants for Chronic Hepatitis B Virus Infection Is Cost-EffectiveGastroenterology, 2010
- Long-term effectiveness and cost-effectiveness of screening for Hepatitis C virus infectionEuropean Journal of Public Health, 2009
- New Therapies for Hepatitis C Virus InfectionClinical Infectious Diseases, 2009
- Revisting wilson and Jungner in the genomic age: a review of screening criteria over the past 40 yearsBulletin of the World Health Organization, 2008
- The way forward in HCV treatment — finding the right pathNature Reviews Drug Discovery, 2007
- Case finding for hepatitis C in primary care: a cost utility analysisFamily Practice, 2006
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005
- Expanded Screening for HIV in the United States — An Analysis of Cost-EffectivenessNew England Journal of Medicine, 2005
- Routine Screening for HIV Infection — Timely and Cost-EffectiveNew England Journal of Medicine, 2005
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001